Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yajun Li PhD"'
Autor:
Can Chen MS, Minjun Chen MS, Yuju Bai MS, Yajun Li PhD, Jie Peng PhD, Biao Yao MS, Jiangping Feng BS, Jian-Guo Zhou PhD, Hu Ma PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Background Cadonilimab (AK104) is a bispecific IgG-single-chain Fv fragment (ScFv) antibody that binds to PD-1 and CTLA-4. Cadonilimab has shown encouraging anti-tumour activity and a favourable safety profile in several tumour types. In second-line
Externí odkaz:
https://doaj.org/article/715ac5fd69c648feadd1463e6244c0bd
